01 — Business
What Assured Guaranty actually does
AGO sells financial guaranty insurance — wrapping bonds so that if the issuer defaults, AGO unconditionally pays principal and interest. Bondholders never miss a payment. AGO then recovers through restructuring.
This is a legally mandated duopoly. The 2008 crisis destroyed every competitor. Today only BAM (a non-profit mutual) competes. AGO controls ~65-70% of new U.S. muni bond insurance issuance. AA-category ratings — the essential credential — take decades to build. There is no new entrant threat.
The economics are excellent: premium income is earned over 20-40 year bond lives, creating a massive deferred premium reserve that generates investment income in parallel. $212.3B net par outstanding means decades of future cash flows even if new business stops. The recent acquisition of Warwick Re (now Assured Life Re) adds annuity reinsurance — a third growth engine alongside the insurance franchise and the 30% stake in Sound Point Capital (a $40B+ AUM credit manager).
02 — Financials
FY2025 results — the numbers that matter
FY25 EPS (GAAP)
$10.26
↑ 49% YoY
2nd highest in company history
Adj. book value / sh
$186.43
↑ 9.6% YoY · record high
+$116.18 from buybacks since 2013
Capital returned FY25
$569M
$500M buybacks · $69M dividends · −10.3% share count
Net par outstanding
$212B
Decades of deferred premium cash flows
| Metric | FY23 | FY24 | FY25 | 23→25 |
|---|
| GAAP EPS | $6.28 | $6.87 | $10.26 | +63% |
| ABV per share | $155.92 | $170.12 | $186.43 | +20% |
| Shares outstanding (M) | 56.2 | 50.5 | 45.2 | −20% |
| Capital returned | $267M | $576M | $569M | — |
| GWP (gross written premiums) | $440M | $440M | $256M | −42% |
| Dividend (annualized) | $1.08 | $1.36 | $1.52 | +41% |
On the GWP decline — not what it looks like
FY25 GWP of $256M vs $440M in FY24 looks alarming. Reality: FY24 was the strongest new issuance year in a decade. And Q4 2025 EPS of $2.32 beat the analyst estimate of $1.49 by 55.7% because loss mitigation gains and investment income more than offset the lower premiums. The company insured $33B of new par in 2025 — the most in a decade — through secondary market wraps that have a different premium recognition pattern than primary issuance. The pipeline is healthy.
03 — Core Thesis
The compounding buyback machine
Since 2013, AGO has repurchased $5.91B of its own stock — retiring ~78% of original shares outstanding — at an average price of $37.73. The cumulative per-share value accretion for remaining shareholders is $116.18 in ABV per share. The math: buying back stock at a discount to intrinsic value means remaining shareholders own a larger share of the same asset base, at no cost to them.
At today's price of $86.64 vs ABV of $186.43: every $1 spent on buybacks creates $1.15 of ABV value for remaining shareholders. The $204M remaining authorization represents ~2.35M shares. The Board has refreshed authorization every year since 2022 — this is structural policy, not a one-off.
Total repurchased 2013–2026
$5.91B
Avg price $37.73 · 156.6M shares retired
ABV accretion from buybacks
+$116/sh
$186.43 vs ~$70 without repurchase program
Value created per $1 at today's price
$1.15
($186.43 − $86.64) ÷ $86.64
04 — Valuation
Six ways to value AGO — all say the same thing
| Approach | Fair value | Upside | Method |
|---|
| Adjusted Book Value (1.0×) | $186.43 | +115% | Company-reported ABV incl. NPV of unearned premiums |
| Peer P/E (sector avg 12×) | $123.12 | +42% | $10.26 EPS × 12× sector avg P/E |
| DCF model | $183.70 | +112% | Discounted future cash flows at 10% discount rate |
| Excess Returns model | $190.68 | +120% | ROE vs cost of equity; stable book $143.55/sh fwd |
| Analyst consensus | $107.00 | +24% | 3 analysts; high $116, low $94 |
| Conservative base (1× GAAP book) | $125.32 | +45% | Without any ABV re-rating; just book value recognition |
Why the discount persists — and why it closes
The market is pricing AGO as a "legacy runoff bond insurer." That was correct in 2010. It is not correct in 2026. Three mechanisms close the discount: (1) continued buybacks that mechanically grow ABV per share regardless of market sentiment; (2) PREPA resolution removing the last legacy overhang that has suppressed the multiple since 2016; (3) strategic acquirer recognizing the franchise value at 46 cents on the dollar. All three are plausible within 24 months.
05 — Risk Map
Stress credits — the honest picture
Total net par outstanding: $212.3B. Below-investment-grade: $6.8B (3.2%). The market has been pricing catastrophic outcomes on all of these since 2016. None has been catastrophic.
PREPA — Puerto Rico Electric Power Authority
Last unresolved PR default. Mediation extended to Apr 30, 2026. 5th amended plan filed Mar 2025. First Circuit Jun 2024: full principal + interest claim confirmed; secured by future net revenues.
$387M
net par
Active default
Thames Water — UK regulated utility
~6% of net par. Class A senior debt — interest current. £1.5bn + £824M accordion liquidity in Q1 2026. CMA final determination Mar 10, 2026. CEO: majority of scenarios = no loss.
~$3.8B
approx
Monitoring
UK Healthcare / student accommodation
Inflation + Medicaid cuts creating cash flow stress. No payment defaults yet. Manageable.
~$800M
Stressed
Puerto Rico (GO, PBA, HTA, CCDA)
Fully resolved. Assured received cash + recovery bonds in full settlement.
~$0
Resolved
Probability-weighted expected loss vs. the capital buffer
Combined stress-scenario expected loss from PREPA + Thames Water: roughly $400-800M against book value of $5.66B and ABV of $8.42B. Even a stress scenario does not impair solvency. Importantly: each quarter of buybacks at 46 cents on ABV narrows the gap between the bear-case loss and the structural discount at which shares trade. The buyback program is providing continuous loss coverage in addition to per-share value creation.
06 — Growth
Three growth vectors the market isn't pricing
Municipal bond insurance renaissance
Penetration fell from ~50% pre-2008 to ~5% at trough; now recovering to ~8-10% as rising rates make the spread tightening valuable and credit concerns drive demand. AGO insured $33B of par in 2025 — the most in a decade. Every 1% increase in market penetration = ~$3-4B additional annual par insured.
Assured Life Re — annuity reinsurance platform
Jan 21, 2026 acquisition of Warwick Re for ~$158M. The $3.5 trillion U.S. defined benefit pension risk transfer market grows ~15% annually. AGO's AA-rated guarantee is a genuine differentiator — most annuity reinsurers can't offer an AA wrap. This segment should contribute meaningfully to revenue within 3 years.
Sound Point — hidden asset management value
30% stake in Sound Point Capital Management (~$40B+ AUM CLO/credit manager). Not reflected at market value in book. At 2-4% of AUM (credit manager market multiples), AGO's 30% stake is worth $240-480M — 6-12% of current market cap — carried at below fair value. Growing AUM means growing fee income with zero additional capital.
07 — Activist Analysis
What an activist would demand — and why it's moot
AGO management is already running the optimal playbook. An activist arriving today finds the value creation engine at full throttle. These are the theoretical demands — most already being executed or in progress.
01
Accelerate buybacks to $600-700M/yr
With $204M remaining and annual refresh history, committing to 15-18% of market cap annually in repurchases — for as long as stock trades below 0.75× ABV — would add $5-8/share ABV annually.
Impact: +$5-8/sh ABV annually
02
Raise dividend more aggressively
$1.52/yr on $10+ EPS is conservative. A $3-4 annual dividend (30-40% payout) would attract yield-oriented buyers currently avoiding AGO. Dividend was just raised 12%; sustaining double-digit annual increases signals confidence.
Impact: +1-2× P/E multiple expansion
03
Settle PREPA — accept reasonable haircut now
The First Circuit lien ruling is a strong hand. Accept 70-80 cents on the dollar in 2026 mediation rather than waiting 3+ more years for 90 cents. The IRR on removing 8 years of multiple suppression almost certainly exceeds the haircut.
Impact: +15-25% P/E expansion on resolution
04
Annual investor day — explain ABV
Most generalist investors don't understand adjusted book value. An ABV bridge presentation walking through the calculation would re-rate the stock on investor comprehension alone. This is $20-30/share sitting in a PowerPoint.
Cost: ~$500K. Potential value: $1B+
05
Monetize Sound Point stake
At credit-manager market multiples, AGO's 30% of Sound Point is worth $240-480M — carried below fair value. A secondary sale or IPO preparation surfaces hidden NAV and redeploys capital into buybacks.
Hidden value: $240-480M (6-12% of market cap)
06
CEO succession plan — and the M&A optionality it unlocks
Frederico is 72, on the board since the 2004 IPO. The average board member age is 69.4 years. Five of nine directors are 70+. This board cohort — built for an era of crisis management and capital return — is approaching natural rotation. A formal succession framework is good governance. But more importantly: a post-Frederico AGO is the most logical acquisition target in specialty insurance. No succession plan = no sale optionality.
Strategic value: acquisition at 1× ABV = +115% to current holders
The activist verdict
There is no compelling case against AGO management. The CEO has been running the optimal capital allocation strategy since 2013 — before most activists were paying attention. An activist showing up today would find Frederico saying "I've been doing exactly what you're suggesting for 12 years." The opportunity here is not activism. It's the market's failure to recognize what's already happening — which is a much better situation than needing to force change.
08 — Bear Case
The legitimate risks — honestly
GWP structural decline — the real risk
FY2025 GWP fell 42%. If muni bond issuance slows as rates fall, or if BAM takes share, new business generation declines structurally. The in-force book provides decades of earned premium regardless — but new business validates the franchise long-term. This, not PREPA, is the legitimate structural concern.
Thames Water — a non-zero tail
AGO guarantees senior Class A debt — the most protected tranche, interest current. But if UK government restructures Thames Water with a Class A haircut (historically unprecedented for UK regulated utilities), AGO faces losses on ~$3.8B exposure. "Majority of scenarios show no loss" ≠ "all scenarios."
Warwick Re — execution risk
Annuity reinsurance is a new risk vector. Wrong mortality/longevity assumptions or increased competition in PRT could generate losses. Management has 40+ years of life re experience, but model risk and integration risk are real.
09 — Strategic Catalyst
The board age thesis — and why AGO is the most logical acqui-hire in specialty insurance
The image below — captured from AGO's own proxy materials — tells a story the market has not priced. The board that built Assured Guaranty from a post-crisis survivor into a compounding capital allocation machine is, collectively, in its early-to-mid seventies. Average board age: 69.4 years. CEO Frederico is 72 and has served since the 2004 IPO. This is not a criticism — it is a structural catalyst.
Boards at this demographic stage tend to execute one of three strategies within a 3-5 year window: (1) orderly CEO succession with an external hire; (2) accelerated return of capital ahead of transition; or (3) a sale of the company at a premium. For AGO, option 3 is uniquely compelling given the persistent discount to ABV — a strategic acquirer could buy the entire franchise at $125/share (1.0× GAAP book) and still be acquiring $186 of adjusted book value for every $125 paid.
The logical acquirers are few but obvious: a large P&C insurer seeking a capital-light, fee-generating credit enhancement franchise; a global reinsurer seeking the muni insurance duopoly position; or a private equity firm that would accelerate the buyback program aggressively and realize the ABV gap. The AA-rated operating subsidiaries, the Sound Point stake, and the new Warwick Re annuity platform collectively represent a franchise that is worth far more to a strategic buyer than the current $3.9B market cap implies.
| Director |
Age |
Since |
Background |
Key Committee |
Succession Signal |
Dominic J. Frederico
CEO & President (non-independent) |
72 |
2004 |
CEO since 2003; former ACE exec; 22-yr tenure |
Executive |
Succession window |
| Francisco L. Borges* |
73 |
2007 |
Former Partner, Ares Management |
Finance |
Near rotation |
| Thomas W. Jones* |
75 |
2015 |
Founder & Sr. Partner, TWJ Capital |
Audit, NG |
Near rotation |
| Bonnie L. Howard* |
71 |
2012 |
Former Chief Auditor, Citigroup |
Compensation, NG |
Near rotation |
| Yukiko Omura* |
69 |
2014 |
Former EVP, MIGA World Bank Group |
Compensation, ES |
Watch (5yr) |
| Mark C. Batten* |
68 |
2024 |
Former Partner, PricewaterhouseCoopers |
Audit, Finance |
Newest member |
| Courtney C. Shea* |
64 |
2021 |
Former Managing Member, Columbia Capital Mgmt |
Audit, Finance |
Stable (10yr) |
| Lorin P.T. Radtke* |
56 |
2021 |
Co-founder, M Seven 8 LLC |
ES, Finance |
Stable (10yr+) |
| Antonio Ursano Jr. |
60 |
2026 |
Managing Partner, Insurance Advisory Partners |
New nominee |
New (2026) |
Average board age
69.4
Top 10% oldest boards in S&P mid-cap universe
Directors aged 70+
4 of 9
Borges (73), Jones (75), Frederico (72), Howard (71)
Acquisition value at 1× ABV
$186.43
vs $86.64 today — acquirer gets +115% on day one
The M&A case — why AGO is the ideal acquisition at current prices
A strategic acquirer buying AGO at $125/share (1× GAAP book — a 44% premium to today) would be paying $5.65B for: (1) a legally mandated duopoly in U.S. muni bond insurance with AA-rated operating subsidiaries that took decades to build; (2) $212B of net par outstanding generating deferred premium cash flows for 20-40 years; (3) a 30% stake in Sound Point Capital (~$40B AUM) worth $240-480M alone; (4) Assured Life Re — a new annuity reinsurance platform; and (5) $204M of pre-authorized share repurchase capacity. The buyer would acquire $186.43 of ABV for $125 paid — an immediate 49% discount to intrinsic value on day one. There is no comparable deal available in specialty finance at this price.
Succession scenarios and their probability-weighted impact
Scenario A — External CEO hire (probability: 40%): A high-profile hire from a major insurer signals strategic ambition and typically triggers a 15-25% re-rating as investors reprice key-man discount. Scenario B — Accelerated buyback program pre-transition (probability: 35%): Board commits to $700M+/yr in repurchases through 2027-28, growing ABV per share to $220+ before any leadership change. Scenario C — Strategic sale (probability: 25%): Board accepts an offer at 0.85-1.0× ABV ($158-$186/share) — a 83-115% premium — in the 2027-2029 window. Any of these scenarios represents a substantial outcome for current shareholders. The current price of $86.64 is not pricing any of them.